Triggers and effectors of oxidative stress at blood-brain barrier level: Relevance for brain ageing and neurodegeneration

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Enciu, Ana Maria ^a,b   Gherghiceanu, Mihaela ^a   Popescu, Bogdan O ^b  

^a VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEMS; FUNDAMENTAL RESEARCH; MOLECULAR MECHANISM; MOLECULAR TRANSFER; PATHOGENIC MECHANISMS; PATHOGENIC PATHWAYS; PROTEIN EXPRESSIONS;

BLOOD; ENDOTHELIAL CELLS; PROTEINS;

OXIDATIVE STRESS;

AMYLOID BETA PROTEIN; GELATINASE A; GELATINASE B; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TIGHT JUNCTION PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

AGING; ALCOHOL CONSUMPTION; BLOOD BRAIN BARRIER; BRAIN HYPOXIA; ENDOTHELIUM CELL; HOMEOSTASIS; HUMAN; LIPID PEROXIDATION; MEMBRANE PERMEABILITY; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REOXYGENATION; REVIEW; SIGNAL TRANSDUCTION; TIGHT JUNCTION; ANIMAL; BRAIN; DEGENERATIVE DISEASE; METABOLISM; PATHOLOGY; ULTRASTRUCTURE;

AGING; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; HUMANS; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; TIGHT JUNCTION PROTEINS;

EID: 84875513508     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/297512     Document Type: Review

References (132)

1. Ceballos-Picot I., Merad-Boudia M., Nicole A., Thevenin M., Hellier G., Legrain S., Berr C., Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer's type-place of the extracellular glutathione peroxidase. Free Radical Biology and Medicine 1996 20 4 579 587 2-s2.0-0029871412 10.1016/0891-5849(95)02058-6 (Pubitemid 26097275)
2. De la Monte S. M., Neely T. R., Cannon J., Wands J. R., Oxidative stress and hypoxia-like injury cause Alzheimer-type molecular abnormalities in central nervous system neurons. Cellular and Molecular Life Sciences 2000 57 10 1471 1481 2-s2.0-0033769804
3. Gella A., Durany N., Oxidative stress in Alzheimer disease. Cell Adhesion and Migration 2009 3 1 88 93 2-s2.0-67049134478 10.4161/cam.3.1.7402
4. Zlokovic B. V., Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends in Neurosciences 2005 28 4 202 208 2-s2.0-13544268809 10.1016/j.tins.2005.02.001 (Pubitemid 40445527)
5. Popescu B. O., Toescu E. C., Popescu L. M., Bajenaru O., Muresanu D. F., Schultzberg M., Bogdanovic N., Blood-brain barrier alterations in ageing and dementia. Journal of the Neurological Sciences 2009 283 99 106
6. Bauer H. C., Traweger A., Zweimueller-Mayer J., New aspects of the molecular constituents of tissue barriers. Journal of Neural Transmission 2011 118 7 21
7. Bednarczyk J., Lukasiuk K., Tight junctions in neurological diseases. Acta Neurobiologiae Experimentalis 2011 71 393 408
8. Bell R. D., Winkler E. A., Sagare A. P., Singh I., LaRue B., Deane R., Zlokovic B. V., Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 2010 68 3 409 427 2-s2.0-78049279739 10.1016/j.neuron.2010.09.043
9. Nakagawa S., Deli M. A., Kawaguchi H., A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochemistry International 2009 54 3-4 253 263 2-s2.0-60949110463 10.1016/j.neuint.2008.12.002
10. Liebner S., Czupalla C. J., Wolburg H., Current concepts of blood-brain barrier development. International Journal of Developmental Biology 2011 55 467 476
11. Abbott N. J., Patabendige A. A. K., Dolman D. E. M., Yusof S. R., Begley D. J., Structure and function of the blood-brain barrier. Neurobiology of Disease 2010 37 1 13 25 2-s2.0-70449529433 10.1016/j.nbd.2009.07.030
12. Correale J., Villa A., Cellular elements of the blood-brain barrier. Neurochemical Research 2009 34 12 2067 2077 2-s2.0-70450263474 10.1007/s11064-009-0081-y
13. Janzer R. C., Raff M. C., Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 1987 325 6101 253 257 2-s2.0-0023108382 (Pubitemid 17049884)
14. Hayashi Y., Nomura M., Yamagishi S., Harada S., Yamashita J., Yamamoto H., Induction of various blood-brain barrier properties in non-neural endothelial cells by close apposition to co-cultured astrocytes. Glia 1997 19 13 26 (Pubitemid 27050446)
15. Zlokovic B. V., Neurodegeneration and the neurovascular unit. Nature Medicine 2010 16 12 1370 1371 2-s2.0-78650011841 10.1038/nm1210-1370
16. Vorbrodt A. W., Dobrogowska D. H., Molecular anatomy of intercellular junctions in brain endothelial and epithelial barriers: electron microscopist's view. Brain Research Reviews 2003 42 3 221 242 2-s2.0-0038730794 10.1016/S0165-0173(03)00177-2 (Pubitemid 36645239)
17. Weber C. R., Dynamic properties of the tight junction barrier. Annals of the New York Academy of Sciences 2012 1257 77 84
18. Stamatovic S. M., Keep R. F., Andjelkovic A. V., Brain endothelial cell-cell junctions: how to "open" the blood brain barrier. Current Neuropharmacology 2008 6 3 179 192 2-s2.0-53249138093 10.2174/157015908785777210
19. Nasdala I., Wolburg-Buchholz K., Wolburg H., Kuhn A., Ebnet K., Brachtendorf G., Samulowitz U., Kuster B., Engelhardt B., Vestweber D., Butz S., A transmembrane tight junction protein selectively expressed on endothelial cells and platelets. Journal of Biological Chemistry 2002 277 18 16294 16303 2-s2.0-0037013246 10.1074/jbc.M111999200 (Pubitemid 34967918)
20. Colgan O. C., Collins N. T., Ferguson G., Murphy R. P., Birney Y. A., Cahill P. A., Cummins P. M., Influence of basolateral condition on the regulation of brain microvascular endothelial tight junction properties and barrier function. Brain Research 2008 1193 84 92 2-s2.0-39149144011 10.1016/j.brainres.2007.11.072
21. Brown R. C., Mark K. S., Egleton R. D., Huber J. D., Burroughs A. R., Davis T. P., Protection against hypoxia-induced increase in blood-brain barrier permeability: role of tight junction proteins and NF B. Journal of Cell Science 2003 116 4 693 700 2-s2.0-0037442659 10.1242/jcs.00264 (Pubitemid 36231308)
22. El Assar M., Angulo J., Vallejo S., Peiro C., Sanchez-Ferrer C. F., Rodriguez-Manas L., Mechanisms involved in the aging-induced vascular dysfunction. Frontiers in Physiology 2012 3, article 132
23. Mayhan W. G., Faraci F. M., Baumbach G. L., Heistad D. D., Effects of aging on responses of cerebral arterioles. American Journal of Physiology 1990 258 4 H1138 H1143 2-s2.0-0025238643 (Pubitemid 20155559)
24. Matz R. L., De Sotomayor M. A., Schott C., Stoclet J. C., Andriantsitohaina R., Vascular bed heterogeneity in age-related endothelial dysfunction with respect to NO and eicosanoids. British Journal of Pharmacology 2000 131 2 303 311 2-s2.0-0033778214
25. Rodríguez-Mañas L., El-Assar M., Vallejo S., López-Dóriga P., Solís J., Petidier R., Montes M., Nevado J., Castro M., Gómez-Guerrero C., Peiró C., Sánchez-Ferrer C. F., Endothelial dysfunction in aged humans is related with oxidative stress and vascular inflammation. Aging Cell 2009 8 3 226 238 2-s2.0-66249112184 10.1111/j.1474-9726.2009.00466.x
26. Mayhan W. G., Arrick D. M., Sharpe G. M., Sun H., Age-related alterations in reactivity of cerebral arterioles: role of oxidative stress. Microcirculation 2008 15 3 225 236 2-s2.0-46449096453 10.1080/10739680701641421
27. Pacher P., Mabley J. G., Soriano F. G., Liaudet L., Szabó C., Endothelial dysfunction in aging animals: the role of poly(ADP-ribose) polymerase activation. British Journal of Pharmacology 2002 135 1347 1350 (Pubitemid 34270904)
28. Donato A. J., Eskurza I., Silver A. E., Levy A. S., Pierce G. L., Gates P. E., Seals D. R., Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium-dependent dilation and upregulation of nuclear factor- B. Circulation Research 2007 100 11 1659 1666 2-s2.0-34250216014 10.1161/01.RES.0000269183.13937.e8 (Pubitemid 46897269)
29. Lee P., Kim J., Williams R., Sandhir R., Gregory E., Brooks W. M., Berman N. E. J., Effects of aging on blood brain barrier and matrix metalloproteases following controlled cortical impact in mice. Experimental Neurology 2012 234 1 50 61 2-s2.0-84857502917 10.1016/j.expneurol.2011.12.016
30. Mooradian A. D., Haas M. J., Chehade J. M., Age-related changes in rat cerebral occludin and zonula occludens-1 (ZO-1). Mechanisms of Ageing and Development 2003 124 2 143 146 2-s2.0-0037292314 10.1016/S0047-6374(02)00041-6 (Pubitemid 36293922)
31. Sandoval K. E., Witt K. A., Age and 17 β -estradiol effects on blood-brain barrier tight junction and estrogen receptor proteins in ovariectomized rats. Microvascular Research 2011 81 2 198 205 2-s2.0-79651474491 10.1016/j.mvr.2010.12.007
32. Blau C. W., Cowley T. R., O'Sullivan J., Grehan B., Browne T. C., Kelly L., Birch A., Murphy N., Kelly A. M., Kerskens C. M., Lynch M. A., The age-related deficit in LTP is associated with changes in perfusion and blood-brain barrier permeability. Neurobiology of Aging 2012 33 5 1005.e23 1005.e35 2-s2.0-84858341691 10.1016/j.neurobiolaging.2011.09.035
33. Timaru-Kast R., Luh C., Gotthardt P., Influence of age on brain edema formation, secondary brain damage and inflammatory response after brain trauma in mice. PLoS ONE 2012 7 e43829
34. Grinberg L. T., Thal D. R., Vascular pathology in the aged human brain. Acta Neuropathologica 2010 119 3 277 290 2-s2.0-77953026083 10.1007/s00401-010- 0652-7
35. Hawkins B. T., Egleton R. D., Pathophysiology of the blood-brain barrier: animal models and methods. Current Topics in Developmental Biology 2007 80 277 309 2-s2.0-35348903108 10.1016/S0070-2153(07)80007-X
36. Bake S., Friedman J. A., Sohrabji F., Reproductive age-related changes in the blood brain barrier: expression of IgG and tight junction proteins. Microvascular Research 2009 78 3 413 424 2-s2.0-71549122565 10.1016/j.mvr.2009. 06.009
37. Ueno M., Sakamoto H., Kanenishi K., Onodera M., Akiguchi I., Hosokawa M., Ultrastructural and permeability features of microvessels in the hippocampus, cerebellum and pons of senescence-accelerated mice (SAM). Neurobiology of Aging 2001 22 3 469 478 2-s2.0-0034986171 10.1016/S0197-4580(01)00213-5 (Pubitemid 32510920)
38. Simpson J. E., Wharton S. B., Cooper J., Alterations of the blood-brain barrier in cerebral white matter lesions in the ageing brain. Neuroscience Letters 2010 486 246 251
39. Viggars A. P., Wharton S. B., Simpson J. E., Matthews F. E., Brayne C., Savva G. M., Garwood C., Drew D., Shaw P. J., Ince P. G., Alterations in the blood brain barrier in ageing cerebral cortex in relationship to Alzheimer-type pathology: a study in the MRC-CFAS population neuropathology cohort. Neuroscience Letters 2011 505 1 25 30 2-s2.0-82455162480 10.1016/j.neulet.2011. 09.049
40. Li C., Jackson R. M., Reactive species mechanisms of cellular hypoxia-reoxygenation injury. American Journal of Physiology 2002 282 2 C227 C241 2-s2.0-0036080614 (Pubitemid 34663181)
41. Krizanac-Bengez L., Hossain M., Fazio V., Mayberg M., Janigro D., Loss of flow induces leukocyte-mediated MMP/TIMP imbalance in dynamic in vitro blood-brain barrier model: role of pro-inflammatory cytokines. American Journal of Physiology 2006 291 4 C740 C749 2-s2.0-33749341863 10.1152/ajpcell.00516.2005 (Pubitemid 44497599)
42. Chen W., Hartman R., Ayer R., Marcantonio S., Kamper J., Tang J., Zhang J. H., Matrix metalloproteinases inhibition provides neuroprotection against hypoxia-ischemia in the developing brain. Journal of Neurochemistry 2009 111 3 726 736 2-s2.0-70349904406 10.1111/j.1471-4159.2009.06362.x
43. Fischer S., Clauss M., Wiesnet M., Renz D., Schafer W., Karliczek G. F., Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO. American Journal of Physiology 1999 276 4 C812 C820 2-s2.0-0032925332 (Pubitemid 29211309)
44. Witt K. A., Mark K. S., Sandoval K. E., Davis T. P., Reoxygenation stress on blood-brain barrier paracellular permeability and edema in the rat. Microvascular Research 2008 75 1 91 96 2-s2.0-37249084760 10.1016/j.mvr.2007.06. 004 (Pubitemid 350266739)
45. Zhao H., Zhang Q., Xue Y., Chen X., Haun R. S., Effects of hyperbaric oxygen on the expression of claudins after cerebral ischemia-reperfusion in rats. Experimental Brain Research 2011 212 1 109 117 2-s2.0-79958865956 10.1007/s00221-011-2702-3
46. Jiao H., Wang Z., Liu Y., Wang P., Xue Y., Specific role of tight junction proteins claudin-5, occludin, and ZO-1 of the blood-brain barrier in a focal cerebral ischemic insult. Journal of Molecular Neuroscience 2011 44 2 130 139 2-s2.0-79955922988 10.1007/s12031-011-9496-4
47. Pillai D. R., Dittmar M. S., Baldaranov D., Heidemann R. M., Henning E. C., Schuierer G., Bogdahn U., Schlachetzki F., Cerebral ischemia-reperfusion injury in rats-a 3 T MRI study on biphasic blood-brain barrier opening and the dynamics of edema formation. Journal of Cerebral Blood Flow and Metabolism 2009 29 11 1846 1855 2-s2.0-71949096119 10.1038/jcbfm.2009.106
48. Neumann-Haefelin T., Kastrup A., De Crespigny A., Serial MRI after transient focal cerebral ischemia in rats: dynamics of tissue injury, blood-brain barrier damage, and edema formation. Stroke 2000 31 8 1965 1973 2-s2.0-0033862478 (Pubitemid 30620481)
49. Lochhead J. J., McCaffrey G., Quigley C. E., Finch J., Demarco K. M., Nametz N., Davis T. P., Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation. Journal of Cerebral Blood Flow and Metabolism 2010 30 1625 1636
50. McCaffrey G., Willis C. L., Staatz W. D., Nametz N., Quigley C. A., Hom S., Lochhead J. J., Davis T. P., Occludin oligomeric assemblies at tight junctions of the blood-brain barrier are altered by hypoxia and reoxygenation stress. Journal of Neurochemistry 2009 110 1 58 71 2-s2.0-67449128444 10.1111/j.1471-4159.2009.06113.x
51. Witt K. A., Mark K. S., Hom S., Davis T. P., Effects of hypoxia-reoxygenation on rat blood-brain barrier permeability and tight junctional protein expression. American Journal of Physiology 2003 285 6 H2820 H2831 2-s2.0-0344009459 (Pubitemid 37443103)
52. Amor S., Puentes F., Baker D., Van Der Valk P., Inflammation in neurodegenerative diseases. Immunology 2010 129 2 154 169 2-s2.0-73949090103 10.1111/j.1365-2567.2009.03225.x
53. Vila N., Castillo J., Dávalos A., Chamorro A., Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 2000 31 10 2325 2329 2-s2.0-0033795665
54. Welsh P., Lowe G. D. O., Chalmers J., Campbell D. J., Rumley A., Neal B. C., MacMahon S. W., Woodward M., Associations of proinflammatory cytokines with the risk of recurrent stroke. Stroke 2008 39 8 2226 2230 2-s2.0-49849103941 10.1161/STROKEAHA.107.504498
55. Tuttolomondo A., Di Raimondo D., di Sciacca R., Pinto A., Licata G., Inflammatory cytokines in acute ischemic stroke. Current Pharmaceutical Design 2008 14 3574 3589
56. Ravaglia G., Forti P., Maioli F., Chiappelli M., Montesi F., Tumini E., Mariani E., Licastro F., Patterson C., Blood inflammatory markers and risk of dementia. The Conselice Study of Brain Aging. Neurobiology of Aging 2007 28 12 1810 1820 2-s2.0-35148823255 10.1016/j.neurobiolaging.2006.08.012 (Pubitemid 47539699)
57. Di Napoli M., Shah I. M., Neuroinflammation and cerebrovascular disease in old age: a translational medicine perspective. Journal of Aging Research 2011 2011 18 10.4061/2011/857484 857484
58. Ray S., Britschgi M., Herbert C., Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nature Medicine 2007 13 1359 1362 (Pubitemid 350073592)
59. Ravetti M. G., Moscato P., Identification of a 5-protein biomarker molecular signature for predicting Alzheimer's disease. PLoS ONE 2008 3 9 2-s2.0-52349110529 10.1371/journal.pone.0003111 e3111
60. Tobinick E. L., Gross H., Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease. BMC Neurology 2008 8, article 27 2-s2.0-49949104408 10.1186/1471-2377-8-27
61. Tobinick E., Perispinal etanercept produces rapid improvement in primary progressive aphasia: identification of a novel, rapidly reversible TNF-mediated pathophysiologic mechanism. Medscape General Medicine 2008 10 6, article 135 2-s2.0-45449115211
62. Patrick D. M., Leone A. K., Shellenberger J. J., Dudowicz K. A., King J. M., Proinflammatory cytokines tumor necrosis factor- α and interferon- γ modulate epithelial barrier function in Madin-Darby canine kidney cells through mitogen activated protein kinase signaling. BMC Physiology 2006 6, article 2 2-s2.0-33645014120 10.1186/1472-6793-6-2
63. Amasheh M., Grotjohann I., Amasheh S., Fromm A., Söderholm J. D., Zeitz M., Fromm M., Schulzke J., Regulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor alpha and interferon gamma in vitro: a novel model for studying the pathomechanisms of inflammatory bowel disease cytokines. Scandinavian Journal of Gastroenterology 2009 44 10 1226 1235 2-s2.0-70350648021 10.1080/00365520903131973
64. Ewert P., Aguilera S., Alliende C., Kwon Y., Albornoz A., Molina C., Urzúa U., Quest A. F. G., Olea N., Pérez P., Castro I., Barrera M., Romo R., Hermoso M., Leyton C., González M., Disruption of tight junction structure in salivary glands from Sjogren's syndrome patients is linked to proinflammatory cytokine exposure. Arthritis and Rheumatism 2010 62 5 1280 1289 2-s2.0-77951711146 10.1002/art.27362
65. Capaldo C. T., Nusrat A., Cytokine regulation of tight junctions. Biochimica et Biophysica Acta 2009 1788 4 864 871 2-s2.0-63249123919 10.1016/j.bbamem.2008.08.027
66. Scharl M., Paul G., Barrett K. E., McCole D. F., AMP-activated protein kinase mediates the interferon- γ -induced decrease in intestinal epithelial barrier function. Journal of Biological Chemistry 2009 284 41 27952 27963 2-s2.0-70350437248 10.1074/jbc.M109.046292
67. Dimitrijevic O. B., Stamatovic S. M., Keep R. F., Andjelkovic A. V., Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury. Journal of Cerebral Blood Flow and Metabolism 2006 26 6 797 810 2-s2.0-33745712943 10.1038/sj.jcbfm.9600229
68. Huber J. D., Witt K. A., Hom S., Egleton R. D., Mark K. S., Davis T. P., Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression. American Journal of Physiology 2001 280 3 H1241 H1248 2-s2.0-0034977693
69. Brooks T. A., Hawkins B. T., Huber J. D., Egleton R. D., Davis T. P., Chronic inflammatory pain leads to increased blood-brain barrier permeability and tight junction protein alterations. American Journal of Physiology 2005 289 2 H738 H743 2-s2.0-23744445782 10.1152/ajpheart.01288.2004 (Pubitemid 41129391)
70. Izikson L., Klein R. S., Charo I. F., Weiner H. L., Luster A. D., Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. Journal of Experimental Medicine 2000 192 7 1075 1080 2-s2.0-0034596949 10.1084/jem.192.7.1075
71. Holman D. W., Klein R. S., Ransohoff R. M., The blood-brain barrier, chemokines and multiple sclerosis. Biochim Biophys Acta 2011 1812 220 230
72. Krumbholz M., Theil D., Steinmeyer F., CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions. Journal of Neuroimmunology 2007 190 1-2 72 79 2-s2.0-35448986091 10.1016/j.jneuroim.2007.07.024 (Pubitemid 47625610)
73. Errede M., Girolamo F., Ferrara G., Blood-brain barrier alterations in the cerebral cortex in experimental autoimmune encephalomyelitis. Journal of Neuropathology and Experimental Neurology 2012 71 840 854
74. Wolburg H., Wolburg-Buchholz K., Kraus J., Rascher-Eggstein G., Liebner S., Hamm S., Duffner F., Grote E., Risau W., Engelhardt B., Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme. Acta Neuropathologica 2003 105 6 586 592 2-s2.0-0038819415 (Pubitemid 36798859)
75. Pfeiffer F., Schäfer J., Lyck R., Makrides V., Brunner S., Schaeren-Wiemers N., Deutsch U., Engelhardt B., Claudin-1 induced sealing of blood-brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis. Acta Neuropathologica 2011 122 5 601 614 2-s2.0-82355190262 10.1007/s00401-011-0883-2
76. Merlini M., Meyer E. P., Ulmann-Schuler A., Nitsch R. M., Vascular β -amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcA β mice. Acta Neuropathologica 2011 122 3 293 311 2-s2.0-80054711185 10.1007/s00401-011-0834-y
77. Hawkes C. A., Härtig W., Kacza J., Schliebs R., Weller R. O., Nicoll J. A., Carare R. O., Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy. Acta Neuropathologica 2011 121 4 431 443 2-s2.0-79954623282 10.1007/s00401-011-0801-7
78. Hartz A. M. S., Bauer B., Soldner E. L. B., Wolf A., Boy S., Backhaus R., Mihaljevic I., Bogdahn U., Klünemann H. H., Schuierer G., Schlachetzki F., Amyloid- β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy. Stroke 2012 43 2 514 523 2-s2.0-84856429045 10.1161/STROKEAHA.111.627562
79. Marlatt M. W., Lucassen P. J., Perry G., Smith M. A., Zhu X., Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies. Journal of Alzheimer's Disease 2008 15 2 199 210 2-s2.0-54249100455
80. Massaad C. A., Neuronal and vascular oxidative stress in Alzheimer's disease. Current Neuropharmacology 2011 9 4 662 673 2-s2.0-82955216246
81. Vinters H. V., Cerebral amyloid angiopathy. A critical review. Stroke 1987 18 2 311 324 2-s2.0-0023254674 (Pubitemid 17059655)
82. Carrano A., Hoozemans J. J. M., Van Der Vies S. M., Rozemuller A. J. M., Van Horssen J., De Vries H. E., Amyloid beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy. Antioxidants and Redox Signaling 2011 15 5 1167 1178 2-s2.0-79960793961 10.1089/ars.2011.3895
83. Askarova S., Yang X., Sheng W., Sun G. Y., Lee J. C., Role of A β -receptor for advanced glycation endproducts interaction in oxidative stress and cytosolic phospholipase A2 activation in astrocytes and cerebral endothelial cells. Neuroscience 2011 199 375 385 2-s2.0-83055176524 10.1016/j.neuroscience. 2011.09.038
84. Biron K. E., Dickstein D. L., Gopaul R., Jefferies W. A., Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in alzheimer's disease. PLoS ONE 2011 6 8 2-s2.0-80052330506 10.1371/journal.pone.0023789 e23789
85. Tai L. M., Holloway K. A., Male D. K., Loughlin A. J., Romero I. A., Amyloid- β -induced occludin down-regulation and increased permeability in human brain endothelial cells is mediated by MAPK activation. Journal of Cellular and Molecular Medicine 2010 14 5 1101 1112 2-s2.0-77954711307 10.1111/j.1582-4934.2009.00717.x
86. Kook S. Y., Hong H. S., Moon M., Ha C. M., Chang S., A β 1-42 -RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca 2 + -calcineurin signaling. Journal of Neuroscience 2012 32 8845 8854
87. Ehrlich D., Pirchl M., Humpel C., Effects of long-term moderate ethanol and cholesterol on cognition, cholinergic neurons, inflammation, and vascular impairment in rats. Neuroscience 2012 205 154 166 2-s2.0-84858009243 10.1016/j.neuroscience.2011.12.054
88. Sun H., Zheng H., Molacek E., Fang Q., Patel K. P., Mayhan W. G., Role of NAD(P)H oxidase in alcohol-induced impairment of endothelial nitric oxide synthase-dependent dilation of cerebral arterioles. Stroke 2006 37 2 495 500 2-s2.0-33644866018 10.1161/01.STR.0000199033.06678.c3 (Pubitemid 43732013)
89. Sun A. Y., Sun G. Y., Ethanol and oxidative mechanisms in the brain. Journal of Biomedical Science 2001 8 1 37 43 2-s2.0-0035137016 10.1159/000054011 (Pubitemid 32098484)
90. Muneer P. M. A., Alikunju S., Szlachetka A. M., Haorah J., The mechanisms of cerebral vascular dysfunction and neuroinflammation by MMP-mediated degradation of VEGFR-2 in alcohol ingestion. Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 5 1167 1177 2-s2.0-84860215152 10.1161/ATVBAHA.112. 247668
91. Haorah J., Knipe B., Leibhart J., Ghorpade A., Persidsky Y., Alcohol-induced oxidative stress in brain endothelial cells causes blood-brain barrier dysfunction. Journal of Leukocyte Biology 2005 78 6 1223 1232 2-s2.0-28844498785 10.1189/jlb.0605340 (Pubitemid 41779228)
92. Haorah J., Heilman D., Knipe B., Chrastil J., Leibhart J., Ghorpade A., Miller D. W., Persidsky Y., Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise. Alcoholism 2005 29 6 999 1009 2-s2.0-21644440553 10.1097/01.ALC.0000166944.79914.0A (Pubitemid 40934204)
93. Zhang Y., Li Q., Guo W., Huang Y., Yang J., Effects of chronic ethanol ingestion on tight junction proteins and barrier function of alveolar epithelium in the rat. Shock 2007 28 2 245 252 2-s2.0-34547670258 10.1097/SHK. 0b013e31803404a9 (Pubitemid 47220838)
94. Rotoli B. M., Orlandini G., Guizzardi S., Ethanol increases the paracellular permeability of monolayers of CAPAN-1 pancreatic duct cells. Journal of Molecular Histology 2004 35 4 355 362 2-s2.0-16644399985 10.1023/B:HIJO.0000039838.56131.02 (Pubitemid 40576021)
95. Elamin E., Jonkers D., Juuti-Uusitalo K., van IJzendoorn S., van IJzendoorn S., Troost F., Duimel H., Broers J., Verheyen F., Dekker J., Masclee A., Effects of ethanol and acetaldehyde on tight junction integrity: in vitro study in a three dimensional intestinal epithelial cell culture model. PLoS ONE 2012 7 4 2-s2.0-84859853683 10.1371/journal.pone.0035008 e35008
96. Atwood C. S., Perry G., Zeng H., Kato Y., Jones W. D., Ling K., Huang X., Moir R. D., Wang D., Sayre L. M., Smith M. A., Chen S. G., Bush A. I., Copper mediates dityrosine cross-linking of Alzheimer's amyloid- β Biochemistry 2004 43 2 560 568 2-s2.0-9144235443 10.1021/bi0358824 (Pubitemid 38082580)
97. Chen C., Lin C., Druhan L. J., Wang T., Chen Y., Zweier J. L., Superoxide induces endothelial nitric-oxide synthase protein thiyl radical formation, a novel mechanism regulating eNOS function and coupling. Journal of Biological Chemistry 2011 286 33 29098 29107 2-s2.0-80051698652 10.1074/jbc.M111.240127
98. Chrissobolis S., Faraci F. M., The role of oxidative stress and NADPH oxidase in cerebrovascular disease. Trends in Molecular Medicine 2008 14 11 495 502 2-s2.0-54449093276 10.1016/j.molmed.2008.09.003
99. Faraci F. M., Hydrogen peroxide: watery fuel for change in vascular biology. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 9 1931 1933 2-s2.0-33747399033 10.1161/01.ATV.0000238355.56172.b3 (Pubitemid 44253772)
100. Schreibelt G., Musters R. J. P., Reijerkerk A., De Groot L. R., Van Der Pol S. M. A., Hendrikx E. M. L., Döpp E. D., Dijkstra C. D., Drukarch B., De Vries H. E., Lipoic acid affects cellular migration into the central nervous system and stabilizes blood-brain barrier integrity. Journal of Immunology 2006 177 4 2630 2637 2-s2.0-33746924887 (Pubitemid 44201022)
101. Haorah J., Ramirez S. H., Schall K., Smith D., Pandya R., Persidsky Y., Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction. Journal of Neurochemistry 2007 101 2 566 576 2-s2.0-34047114464 10.1111/j.1471-4159.2006.04393.x (Pubitemid 46525283)
102. Lee H., Namkoong K., Kim D., Kim K., Cheong Y., Kim S., Lee W., Kim K., Hydrogen peroxide-induced alterations of tight junction proteins in bovine brain microvascular endothelial cells. Microvascular Research 2004 68 3 231 238 2-s2.0-14244257768 10.1016/j.mvr.2004.07.005 (Pubitemid 40288119)
103. Schreibelt G., Kooij G., Reijerkerk A., Van Doorn R., Gringhuis S. I., Van Der Pol S., Weksler B. B., Romero I. A., Couraud P., Piontek J., Blasig I. E., Dijkstra C. D., Ronken E., De Vries H. E., Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB Journal 2007 21 13 3666 3676 2-s2.0-35948971753 10.1096/fj.07-8329com (Pubitemid 350075154)
104. Angeles Muñoz-Fernández M., Fresno M., The role of tumour necrosis factor, interleukin 6, interferon- γ and inducible nitric oxide synthase in the development and pathology of the nervous system. Progress in Neurobiology 1998 56 3 307 340 2-s2.0-0344157469 10.1016/S0301-0082(98)00045-8 (Pubitemid 28389722)
105. Wilcock D. M., Lewis M. R., Van Nostrand W. E., Davis J., Previti M. L., Gharkholonarehe N., Vitek M. P., Colton C. A., Progression of amyloid pathology to Alzheimer's disease pathology in an amyloid precursor protein transgenic mouse model by removal of nitric oxide synthase 2. Journal of Neuroscience 2008 28 7 1537 1545 2-s2.0-39549115445 10.1523/JNEUROSCI.5066-07.2008 (Pubitemid 351287042)
106. Eliasson M. J. L., Huang Z., Ferrante R. J., Sasamata M., Molliver M. E., Snyder S. H., Moskowitz M. A., Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage. Journal of Neuroscience 1999 19 14 5910 5918 2-s2.0-0033565586 (Pubitemid 29327926)
107. Bevers L. M., Braam B., Post J. A., Van Zonneveld A. J., Rabelink T. J., Koomans H. A., Verhaar M. C., Joles J. A., Tetrahydrobiopterin, but not L-arginine, decreases NO synthase uncoupling in cells expressing high levels of endothelial NO synthase. Hypertension 2006 47 1 87 94 2-s2.0-31744447370 10.1161/01.HYP.0000196735.85398.0e (Pubitemid 43177820)
108. Utepbergenov D. I., Mertsch K., Sporbert A., Tenz K., Paul M., Haseloff R. F., Blasig I. E., Nitric oxide protects blood-brain barrier in vitro from hypoxia/reoxygenation-mediated injury. FEBS Letters 1998 424 3 197 201 2-s2.0-0032513129 10.1016/S0014-5793(98)00173-2 (Pubitemid 28135313)
109. Jones D. P., Radical-free biology of oxidative stress. American Journal of Physiology 2008 295 4 C849 C868 2-s2.0-55149107716 10.1152/ajpcell.00283.2008
110. Skoumalova A., Hort J., Blood markers of oxidative stress in Alzheimer's disease. Journal of Cellular and Molecular Medicine 2012 16 2291 2300
111. Skoumalova A., Madlova P., Topinkova E., End products of lipid peroxidation in erythrocyte membranes in Alzheimer's disease. Cell Biochemistry and Function 2012 30 205 210
112. Wang J., Sun L., Si Y. F., Li B. M., Overexpression of actin-depolymerizing factor blocks oxidized low-density lipoprotein-induced mouse brain microvascular endothelial cell barrier dysfunction. Molecular and Cellular Biochemistry 2012 371 1 8
113. Mertsch K., Blasig I., Grune T., 4-Hydroxynonenal impairs the permeability of an in vitro rat blood-brain barrier. Neuroscience Letters 2001 314 3 135 138 2-s2.0-0035900210 10.1016/S0304-3940(01)02299-6 (Pubitemid 33043785)
114. Elali A., Doeppner T. R., Zechariah A., Hermann D. M., Increased blood-brain barrier permeability and brain edema after focal cerebral ischemia induced by hyperlipidemia: role of lipid peroxidation and calpain-1/2, matrix metalloproteinase-2/9, and rhoa overactivation. Stroke 2011 42 11 3238 3244 2-s2.0-80054994555 10.1161/STROKEAHA.111.615559
115. Montaner J., Alvarez-Sabín J., Molina C., Anglés A., Abilleira S., Arenillas J., González M. A., Monasterio J., Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke 2001 32 8 1759 1766 2-s2.0-0034893137 (Pubitemid 32772204)
116. Asahi M., Wang X., Mori T., Sumii T., Jung J., Moskowitz M. A., Fini M. E., Lo E. H., Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. Journal of Neuroscience 2001 21 19 7724 7732 2-s2.0-0035478029 (Pubitemid 32904971)
117. Rosenberg G. A., Kornfeld M., Estrada E., Kelley R. O., Liotta L. A., Stetler-Stevenson W. G., TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase. Brain Research 1992 576 2 203 207 2-s2.0-0026558127 10.1016/0006-8993(92)90681-X
118. Liu J., Jin X., Liu K. J., Liu W., Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage. Journal of Neuroscience 2012 32 9 3044 3057 2-s2.0-84857530337 10.1523/JNEUROSCI.6409-11. 2012
119. Bauer A. T., Bürgers H. F., Rabie T., Marti H. H., Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. Journal of Cerebral Blood Flow and Metabolism 2010 30 4 837 848 2-s2.0-77950516409 10.1038/jcbfm.2009.248
120. Saitou M., Furuse M., Sasaki H., Complex phenotype of mice lacking occludin, a component of tight junction strands. Molecular Biology of the Cell 2000 11 12 4131 4142 2-s2.0-0033635344
121. Saitou M., Fujimoto K., Doi Y., Itoh M., Fujimoto T., Furuse M., Takano H., Noda T., Tsukita S., Occludin-deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions. Journal of Cell Biology 1998 141 2 397 408 2-s2.0-0032550221 10.1083/jcb.141.2.397 (Pubitemid 28237088)
122. Schulzke J. D., Gitter A. H., Mankertz J., Epithelial transport and barrier function in occludin-deficient mice. Biochimica et Biophysica Acta 2005 1669 1 34 42 2-s2.0-17444392533 10.1016/j.bbamem.2005.01.008 (Pubitemid 40544519)
123. Krause G., Winkler L., Mueller S. L., Haseloff R. F., Piontek J., Blasig I. E., Structure and function of claudins. Biochimica et Biophysica Acta 2008 1778 3 631 645 2-s2.0-39849091788 10.1016/j.bbamem.2007.10.018
124. Fleegal M. A., Hom S., Borg L. K., Davis T. P., Activation of PKC modulates blood-brain barrier endothelial cell permeability changes induced by hypoxia and posthypoxic reoxygenation. American Journal of Physiology 2005 289 5 H2012 H2019 2-s2.0-27144446361 10.1152/ajpheart.00495.2005 (Pubitemid 41507352)
125. Chen Y., Lu Q., Schneeberger E. E., Goodenough D. A., Restoration of tight junction structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in Ras-transformed Madin-Darby canine kidney cells. Molecular Biology of the Cell 2000 11 3 849 862 2-s2.0-0034099223 (Pubitemid 30159306)
126. Wang Z., Mandell K. J., Parkos C. A., Mrsny R. J., Nusrat A., The second loop of occludin is required for suppression of Raf1-induced tumor growth. Oncogene 2005 24 27 4412 4420 2-s2.0-21744433348 10.1038/sj.onc.1208634 (Pubitemid 40961764)
127. Li D., Mrsny R. J., Oncogenic Raf-1 disrupts epithelial tight junctions via downregulation of occludin. Journal of Cell Biology 2000 148 4 791 800 2-s2.0-0034695923 10.1083/jcb.148.4.791
128. Hopkins A. M., Walsh S. V., Verkade P., Boquet P., Nusrat A., Constitutive activation of Rho proteins by CNF-1 influences tight junction structure and epithelial barrier function. Journal of Cell Science 2003 116 4 725 742 2-s2.0-0037442918 10.1242/jcs.00300 (Pubitemid 36231311)
129. Basuroy S., Seth A., Elias B., Naren A. P., Rao R., MAPK interacts with occludin and mediates EGF-induced prevention of tight junction disruption by hydrogen peroxide. Biochemical Journal 2006 393 1 69 77 2-s2.0-30044442771 10.1042/BJ20050959 (Pubitemid 43049303)
130. Severson E. A., Kwon M., Hilgarth R. S., Parkos C. A., Nusrat A., Glycogen Synthase Kinase 3 (GSK-3) influences epithelial barrier function by regulating Occludin, Claudin-1 and E-cadherin expression. Biochemical and Biophysical Research Communications 2010 397 3 592 597 2-s2.0-77954217700 10.1016/j.bbrc.2010.05.164
131. Mark K. S., Davis T. P., Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation. American Journal of Physiology 2002 282 4 H1485 H1494 2-s2.0-0036084919 (Pubitemid 34654903)
132. Feng S., Cen J., Huang Y., Shen H., Yao L., Wang Y., Chen Z., Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins. PLoS ONE 2011 6 8 2-s2.0-80051709700 10.1371/journal.pone.0020599 e20599